Interestingly, a recent study by Ariffin et al. indicates that the upregulation of RUNX1 in breast cancer is associated with better outcomes and increases relapse-free survival, providing insight into developing novel therapeutic strategies for BC [156,158]. The gene discussed is RUNX1; the disease is breast cancer.